Eli Lilly’s next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial

by
News PRO
December 11, 2025

The drugmaker is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill. Read More

Related

Related Topics

More in Financial News

Denmark faces data center reckoning as power grid overwhelmed by surging demand

The data center industry is facing a reckoning as governments around the world consider...
Meme stock GameStop makes $56 billion bid for eBay in bid to rival Amazon

GameStop made a takeover bid for eBay, offering $125 per share in a cash-and-stock...
CNBC Daily Open: Trump’s Hormuz gambit lands with a whimper

Markets appear to have made their peace with the stalled talks, with oil barely...
Rudy Giuliani, former New York mayor and Trump lawyer, hospitalized in critical condition

President Donald Trump called Rudy Giuliani a “True Warrior, and the Best Mayor in...

U.S. arrests plummet 25% since onset of the COVID-19 pandemic, analysis finds

‘Reflation is back’ says Deutsche Bank as global central banks diverge from Fed